Genky DrugStores Co., Ltd.

9267.T
Pharmaceutical Retailers
2026/08/24 Updated
Market Cap: $704.4M (¥112.2B)
Stock Price: $23.11 (¥3,680)
Exchange Rate: 1 USD = ¥159.24

FY2026 June Period Financial Summary Supplementary Materials

For the fiscal year ended June 2026, sales reached 221.2 billion yen (+10.2% YoY), operating income was 11.05 billion yen (+14.45% YoY), and net income attributable to owners of parent was 7.85 billion yen (+11.15% YoY), achieving both revenue and profit growth.

Importance:
Page Updated: April 28, 2026
IR Disclosure Date: April 28, 2026

Key Figures

  • Revenue: 221.2 billion yen (YoY +10.2%)
  • Operating Income: 11.05 billion yen (YoY +14.45%)
  • Net Income Attributable to Owners of Parent: 7.85 billion yen (YoY +11.15%)

AI要約

Performance Overview

Revenue for the fiscal year ended June 2026 reached 221.2 billion yen, representing a 10.2% increase year-over-year. Operating income was 11.05 billion yen, up 14.45% YoY, and net income attributable to owners of parent was 7.85 billion yen, an 11.15% increase, achieving growth in both revenue and profit. The number of stores expanded to 538, reflecting the success of an aggressive store expansion strategy. The gross profit margin remained stable at approximately 20.43%, and the SG&A expense ratio was efficiently maintained at 15.44%. Costs such as labor, sales promotion, and equipment expenses have been properly managed.

Financial Indicators and Future Outlook

The equity ratio remains healthy at 41.8%, with high profitability indicated by an ROE of 14.2% and ROA of 8.2%. Operating cash flow is stable, and capital expenditures are trending downward. The company plans to continue expanding its store network while aiming to improve profitability. Although the impact of exchange rates is limited, attention will continue to be paid to changes in the market environment.

Revenue Trend (FY2020–FY2026)

Operating Income Trend (FY2020–FY2026)

Net Income Attributable to Owners of Parent Trend (FY2020–FY2026)

Store Count Trend (FY2020–FY2026)

Gross Profit Margin Trend (FY2020–FY2026)

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Genky DrugStores Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →